• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估意大利甲状腺不定性结节的细胞学分类为 TIR-3A 和 TIR-3B:单机构回顾性研究 290 例与组织学相关性。

Evaluation of the Italian cytological subclassification of thyroid indeterminate nodules into TIR-3A and TIR-3B: a retrospective study of 290 cases with histological correlation from a single institution.

机构信息

Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo-Patologiche, Università Sapienza, Viale Regina Elena, 324, 00161, Rome, Italy.

Unità di Statistica, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy.

出版信息

J Endocrinol Invest. 2018 May;41(5):531-538. doi: 10.1007/s40618-017-0763-2. Epub 2017 Sep 25.

DOI:10.1007/s40618-017-0763-2
PMID:28948534
Abstract

PURPOSE

The Italian consensus to classify thyroid cytology has provided a standardized reporting scheme, including the subdivision of indeterminate for malignancy TIR-3 category into TIR-3A (low-risk) and TIR-3B (high-risk). We aimed to present our experience on this subclassification by evaluating risks of malignancy and the validity in sorting nodules with dissimilar risks. Another aim was to compare our performance against the Bethesda system.

METHODS

Fine-needle aspirates of 290 TIR-3 that underwent thyroid surgery at our hospital (2008-2013) were reviewed and divided into TIR-3A or TIR-3B, and AUS/FLUS or FN/SFN. Cytological diagnoses were then correlated to histology. Results were evaluated using univariate analysis.

RESULTS

The subclassification into TIR-3A and TIR-3B differentiated hyperplastic nodules (p = 0.000) but not adenomas (p = 0.090). Rates of malignancy were significantly different between TIR-3A (10.2%) and TIR-3B (43.8%); TIR-3B malignancies were often papillary carcinomas (83%). TIR-3A/TIR-3B accounted for high sensitivity (84.5%; CI 79.7-88.4%), accuracy (64.1%; CI 58.6-69.6%) and NPV (89.8%; CI 85.6-93.0%) as opposed to modest specificity (55.8%; CI 49.9-61.6%) and PPV (43.8%; CI 38.1-49.8%). The rate of malignancy in AUS-FLUS was higher than in TIR-3A (p = 0.007), whereas it was not different between FN/SFN and TIR-3B (p = 0.337). Sensitivity of the Bethesda system was significantly lower respect to the Italian system.

CONCLUSIONS

The study supports the Italian consensus showing a different risk of malignancy for TIR-3A as compared to TIR-3B. TIR-3A/TIR-3B subclassification is valid to sort out benign nodules (high NPV) and malignancies (high sensitivity) but not adenomas (modest specificity, low PPV). In our experience, sensitivity is the main difference between Italian and Bethesda systems.

摘要

目的

意大利共识对甲状腺细胞学的分类提供了一个标准化的报告方案,包括将恶性不确定的 TIR-3 类别细分为 TIR-3A(低风险)和 TIR-3B(高风险)。我们旨在通过评估恶性风险和对不同风险结节进行分类的有效性来介绍我们在这一分级上的经验。另一个目的是将我们的表现与 Bethesda 系统进行比较。

方法

回顾了我院(2008-2013 年) 290 例 TIR-3 细针抽吸的甲状腺手术,分为 TIR-3A 或 TIR-3B、AUS/FLUS 或 FN/SFN。然后将细胞学诊断与组织学相关联。使用单变量分析评估结果。

结果

TIR-3A 和 TIR-3B 的亚分类可区分增生性结节(p=0.000),但不能区分腺瘤(p=0.090)。TIR-3A(10.2%)和 TIR-3B(43.8%)之间的恶性肿瘤发生率有显著差异;TIR-3B 恶性肿瘤通常为乳头状癌(83%)。TIR-3A/TIR-3B 具有较高的敏感性(84.5%;95%CI 79.7-88.4%)、准确性(64.1%;95%CI 58.6-69.6%)和阴性预测值(89.8%;95%CI 85.6-93.0%),而非特异性(55.8%;95%CI 49.9-61.6%)和阳性预测值(43.8%;95%CI 38.1-49.8%)适中。AUS-FLUS 的恶性肿瘤发生率高于 TIR-3A(p=0.007),而 FN/SFN 与 TIR-3B 之间无差异(p=0.337)。与意大利系统相比,Bethesda 系统的敏感性显著降低。

结论

该研究支持意大利共识,表明 TIR-3A 与 TIR-3B 的恶性风险不同。TIR-3A/TIR-3B 亚分类可有效区分良性结节(高阴性预测值)和恶性肿瘤(高敏感性),但不能区分腺瘤(特异性适中,阳性预测值低)。根据我们的经验,敏感性是意大利和 Bethesda 系统之间的主要区别。

相似文献

1
Evaluation of the Italian cytological subclassification of thyroid indeterminate nodules into TIR-3A and TIR-3B: a retrospective study of 290 cases with histological correlation from a single institution.评估意大利甲状腺不定性结节的细胞学分类为 TIR-3A 和 TIR-3B:单机构回顾性研究 290 例与组织学相关性。
J Endocrinol Invest. 2018 May;41(5):531-538. doi: 10.1007/s40618-017-0763-2. Epub 2017 Sep 25.
2
Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.甲状腺结节的组织学诊断与突变组检测之间的相关性:一项为期两年的机构经验
Thyroid. 2016 Aug;26(8):1068-76. doi: 10.1089/thy.2016.0048. Epub 2016 Jul 12.
3
Performance of Italian Consensus for the Classification and Reporting of Thyroid Cytology (ICCRTC) in discriminating indeterminate lesions at low and high risk of malignancy. A systematic review and meta-analysis.意大利甲状腺细胞病理学分类和报告共识(ICCRTC)在鉴别低危和高危恶性肿瘤不确定病变中的性能。系统评价和荟萃分析。
Endocrine. 2018 Apr;60(1):31-35. doi: 10.1007/s12020-017-1382-6. Epub 2017 Aug 7.
4
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis.意大利甲状腺细胞学分类和报告共识:低危和高危不典型病变的恶性风险。系统评价和荟萃分析。
Endocrine. 2019 Mar;63(3):430-438. doi: 10.1007/s12020-018-1825-8. Epub 2018 Dec 5.
5
A Monocentric Retrospective Study about the Correlation between Histology and Cytology of Thyroid Indeterminate Nodules Classified as TIR 3A and TIR 3B, according to 2014 Italian Consensus for Classification and Reporting of Thyroid Cytology.一项关于根据2014年意大利甲状腺细胞病理学分类与报告共识被分类为TIR 3A和TIR 3B的甲状腺不确定结节组织学与细胞学相关性的单中心回顾性研究。
Adv Med. 2019 Oct 8;2019:3932721. doi: 10.1155/2019/3932721. eCollection 2019.
6
Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.2017年《甲状腺细胞病理学报告贝塞斯达系统》诊断标准修订的影响:日本一家机构的报告
Endocr J. 2018 Dec 28;65(12):1193-1198. doi: 10.1507/endocrj.EJ18-0290. Epub 2018 Oct 3.
7
Histologic Outcome of Indeterminate Thyroid Nodules Classified at Low or High Risk.低危或高危甲状腺结节的组织学结果。
Endocr Pathol. 2018 Mar;29(1):75-79. doi: 10.1007/s12022-018-9517-8.
8
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution.意大利甲状腺细胞病理学分类及报告共识:单中心 37371 例结节的细胞病理学与分子学相关性。
Cancer Cytopathol. 2022 Nov;130(11):899-912. doi: 10.1002/cncy.22618. Epub 2022 Jul 5.
9
Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.基于细针抽吸细胞学和韩国甲状腺影像报告和数据系统的细胞学-超声风险分层评分系统。
Thyroid. 2017 Jul;27(7):953-959. doi: 10.1089/thy.2016.0603. Epub 2017 May 19.
10
Risk of malignancy in thyroid nodules classified as TIR-3A: What therapy?甲状腺结节 TIR-3A 分类的恶性肿瘤风险:何种治疗?
Int J Surg. 2017 May;41 Suppl 1:S60-S64. doi: 10.1016/j.ijsu.2017.03.056.

引用本文的文献

1
Thyroid Nodule Characterization: Overview and State of the Art of Diagnosis with Recent Developments, from Imaging to Molecular Diagnosis and Artificial Intelligence.甲状腺结节的特征描述:从影像学检查到分子诊断及人工智能的最新进展概述与诊断技术现状
Biomedicines. 2024 Jul 26;12(8):1676. doi: 10.3390/biomedicines12081676.
2
Thyroid Nodules with Indeterminate FNAC According to the Italian Classification System: Prevalence, Rate of Operation, and Impact on Risk of Malignancy. An Updated Systematic Review and Meta-analysis.根据意大利分类系统,甲状腺细针穿刺细胞学检查结果不确定的甲状腺结节:患病率、手术率及对恶性肿瘤风险的影响。一项更新的系统评价和荟萃分析。
Endocr Pathol. 2022 Dec;33(4):457-471. doi: 10.1007/s12022-022-09729-x. Epub 2022 Aug 31.
3

本文引用的文献

1
Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid.鉴别贝塞斯达IV类甲状腺病变与甲状旁腺病变的细胞形态学特征。
Cytojournal. 2017 Apr 28;14:10. doi: 10.4103/1742-6413.205313. eCollection 2017.
2
Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.贝塞斯达不确定分类中的恶性肿瘤风险和瘤形成风险:对印度一家机构的4532例甲状腺细针穿刺抽吸术的研究
Acta Cytol. 2017;61(2):103-110. doi: 10.1159/000470825. Epub 2017 Apr 14.
3
Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.
Predictive factors of malignancy in pediatric patients with thyroid nodules and performance of the Italian classification (SIAPEC 2014) in the outcome of the cytological FNA categories.甲状腺结节患儿恶性肿瘤的预测因素及意大利分类(SIAPEC 2014)在细胞学细针抽吸(FNA)分类结果中的应用。
Endocrine. 2021 Nov;74(2):365-374. doi: 10.1007/s12020-021-02784-0. Epub 2021 Jun 14.
4
Impact of the Italian Society of Anatomic Pathology and Diagnostic Cytology Classification of Thyroid Nodules in the Treatment of Indeterminate Follicular Lesions: Five-Year Results at a Single Center.意大利解剖病理学和诊断细胞学学会甲状腺结节分类对不确定滤泡性病变治疗的影响:单中心五年结果
Int J Endocrinol. 2020 Apr 14;2020:7325260. doi: 10.1155/2020/7325260. eCollection 2020.
5
A Monocentric Retrospective Study about the Correlation between Histology and Cytology of Thyroid Indeterminate Nodules Classified as TIR 3A and TIR 3B, according to 2014 Italian Consensus for Classification and Reporting of Thyroid Cytology.一项关于根据2014年意大利甲状腺细胞病理学分类与报告共识被分类为TIR 3A和TIR 3B的甲状腺不确定结节组织学与细胞学相关性的单中心回顾性研究。
Adv Med. 2019 Oct 8;2019:3932721. doi: 10.1155/2019/3932721. eCollection 2019.
6
Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category.具有 Hurthle 细胞的甲状腺结节:与细针穿刺结果分类相关的恶性风险。
J Endocrinol Invest. 2019 Nov;42(11):1319-1327. doi: 10.1007/s40618-019-01055-0. Epub 2019 May 10.
7
A lute player peasant with nodular goiter by Bartolomeo Passarotti (1529-1592).巴托洛梅奥·帕萨罗蒂(1529 - 1592)所作的一位患有结节性甲状腺肿的弹鲁特琴的农民
J Endocrinol Invest. 2019 Jul;42(7):869-870. doi: 10.1007/s40618-019-1004-7. Epub 2019 Jan 9.
8
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis.意大利甲状腺细胞学分类和报告共识:低危和高危不典型病变的恶性风险。系统评价和荟萃分析。
Endocrine. 2019 Mar;63(3):430-438. doi: 10.1007/s12020-018-1825-8. Epub 2018 Dec 5.
9
Cancer Rate of the Indeterminate Lesions at Low or High Risk According to Italian System for Reporting of Thyroid FNA.根据意大利甲状腺细针穿刺活检报告系统,低风险或高风险不确定病变的癌症发生率
Front Endocrinol (Lausanne). 2018 Jul 10;9:371. doi: 10.3389/fendo.2018.00371. eCollection 2018.
10
Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules.新的 SIAPEC-IAP 分类对甲状腺结节不确定类别临床影响。
J Endocrinol Invest. 2019 Jan;42(1):1-6. doi: 10.1007/s40618-018-0871-7. Epub 2018 Mar 15.
超声检查评分系统可排除细胞学检查结果不确定的甲状腺结节的恶性病变。
Endocrine. 2017 Aug;57(2):256-261. doi: 10.1007/s12020-016-1148-6. Epub 2016 Oct 31.
4
Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis.贝塞斯达分类法在甲状腺细针穿刺中的应用:机构经验与荟萃分析。
Arch Pathol Lab Med. 2016 Oct;140(10):1121-31. doi: 10.5858/arpa.2015-0154-SA.
5
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
6
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology.具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP):甲状腺外科病理学的转变范例及其对甲状腺细胞病理学的影响
Cancer Cytopathol. 2016 Sep;124(9):616-20. doi: 10.1002/cncy.21744. Epub 2016 May 20.
7
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.“具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤”的细胞学特征及其与肿瘤组织学的相关性。
Hum Pathol. 2016 Aug;54:134-42. doi: 10.1016/j.humpath.2016.03.014. Epub 2016 Apr 13.
8
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.包膜滤泡型甲状腺乳头状癌命名法修订:减少惰性肿瘤过度治疗的范式转变。
JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.
9
Outcome of Subclassification of Indeterminate (Thy-3) Thyroid Cytology into Thy-3a and Thy-3f.不确定(Thy-3)甲状腺细胞学亚分类为Thy-3a和Thy-3f的结果。
Eur Thyroid J. 2015 Dec;4(4):246-51. doi: 10.1159/000441221. Epub 2015 Oct 27.
10
Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.甲状腺特异性转录因子的基因表达可能有助于诊断甲状腺病变,但并非肿瘤进展的决定因素。
J Endocrinol Invest. 2016 Apr;39(4):423-9. doi: 10.1007/s40618-015-0386-4. Epub 2015 Sep 14.